RB1 and neoplasm: The two components of the tumor revealed similar genomic signatures and pathogenic variants, and both harbored identical point mutations in PTEN c.610C>G, RB1 c.55G>T, and TERT promoter c.146C>T, as well as TP53 c.796G>A and c.586C>T.